YMYani Glaúcia Gomide Mizubuti

Yani Glaúcia Gomide Mizubuti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yani Glaúcia Gomide Mizubuti has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immunological Impact of Whey Protein on Peripheral Blood Mononuclear Cells of Patients with Chronic Liver Disease

    by Yani Gláucia Gomide Mizubuti, Maria Isabel Toulson Davisson Correia, Thales Antônio da Silva, Simone de Vasconcelos Generoso, Antônio Lúcio Teixeira, Agnaldo Soares Lima, Érica Leandro Marciano Vieira

    Background: Recent in vitro studies point to the immune properties of milk proteins. Objective: To investigate the immunomodulating properties of whey protein isolate (WHEY) compared to those of casein (CAS) on peripheral blood mononuclear cell (PBMC) death and supernatant cytokine levels in chronic liver disease (CLD) patients and healthy individuals. Method: The role of WHEY on the immune cells was evaluated under-stimulated and non-stimulated conditions to determine cellular death and cytokine production, post-exposure with 40, 400 or 4.000 μg mL-1 of WHEY or CAS. Flow cytometry was used to identify the monocyte and lymphocyte population. Cytokines were measured from the supernatants of 24 hour-old PBMC cultures. Results: Compared to CAS, WHEY significantly decreased lymphocyte death at 4.000 μg mL-1 in both groups of individuals with no effects on the monocyte population regardless of the group. At the same concentration (4.000 μg mL-1), WHEY increased TNF and IL-10 cytokine levels in the stimulated PBMC supernatant from CLD patients. Conclusion: Compared to CAS, WHEY exerted immunomodulating effects in CLD patients. A similar response may be anticipated for other pathological conditions in which high stress and immune dysfunction are present.

  • Open Access

    SHORT-TERM EFFECT OF WHEY PROTEIN SUPPLEMENTATION ON THE QUALITY OF LIFE OF PATIENTS WAITING FOR LIVER TRANSPLANTATION: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL

    by Michelle Carvalho de Oliveira D’aLessandro, Amanda Dias Gomes, Jéssica França Morais, Yani Glaúcia Gomide Mizubuti, Thales Antônio da Silva, Silvia Mauricio Fernandes, Larissa Loures Mendes, Maria Isabel Toulson Davisson Correia, Simone de Vasconcelos Generoso

    Background: Chronic liver disease is associated with malnutrition that negatively impacts a patient’s health-related quality of life (HRQoL). Aim: To evaluate the short-term effect of whey protein supplementation on the HRQoL and nutritional and functional status of patients waiting for liver transplantation. Methods: This was a double-blind randomized clinical trial with patients waiting for liver transplantation who were randomized into two groups: WP (whey protein supplementation) and the control (casein supplementation). Both groups received 40 g (20 g in the morning and 20 g in the evening) for 15 days. Nutritional and functional status were evaluated. Energy balance was calculated as the difference between energy intake (24-hour recall) and total energy expenditure (assessed by indirect calorimetry). The chronic liver disease questionnaire was used to assess HRQoL. All measurements were performed before and after the intervention. Results: Fifty-six patients were evaluated. Malnutrition was present in 56.9%, and it was directly associated with a poor HRQoL (p0.05). Patients who met protein requirements and had a positive energy balance demonstrated a higher HRQoL score (4.9, p<0.05), without between-group differences. Conclusion: Malnutrition substantially reduces HRQoL. Short-term WP or casein supplementation improved similarly the HRQoL.